Display options
Share it on

Mult Scler Relat Disord. 2021 Nov 29;57:103431. doi: 10.1016/j.msard.2021.103431. Epub 2021 Nov 29.

Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis.

Multiple sclerosis and related disorders

Antonio Luca Spiezia, Vincenza Cerbone, Eduardo Alberto Molinari, Nicola Capasso, Roberta Lanzillo, Antonio Carotenuto, Maria Petracca, Federica Novarella, Bianca Covelli, Giulia Scalia, Vincenzo Brescia Morra, Marcello Moccia

Affiliations

  1. Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Sciences and Odontostomatology, Federico II University of Naples, Naples, Italy.
  2. Centre for Advanced Biotechnology (CEINGE), Naples, Italy.
  3. Department of Translational Medical Sciences, Federico II University of Naples, Naples, Italy.
  4. Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Sciences and Odontostomatology, Federico II University of Naples, Naples, Italy. Electronic address: [email protected].

PMID: 34871857 DOI: 10.1016/j.msard.2021.103431

[No abstract available.]

Keywords: Cladribine; Immunoglobulin; Lymphocytes; Multiple sclerosis

Publication Types